All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: Cell line-39657661

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	39657661	D215G	S	S	Cell line		View
2	39657661	D614G	S	S	Cell line		View
3	39657661	D80A	S	S	Cell line		View
4	39657661	F486P	S	S	Cell line	I	View
5	39657661	G252V	S	S	Cell line	I	View
6	39657661	G339D	S	S	Cell line	I	View
7	39657661	G339H	S	S	Cell line	I	View
8	39657661	H655Y	S	S	Cell line		View
9	39657661	R214insEPE	S	S	Cell line	I	View
10	39657661	K417T	S	S	Cell line	I	View
11	39657661	L368I	S	S	Cell line	I	View
12	39657661	M1229I	S	S	Cell line	I	View
13	39657661	N460K	S	S	Cell line		View
14	39657661	P26S	S	S	Cell line	I	View
15	39657661	Q677H	S	S	Cell line		View
16	39657661	S477N	S	S	Cell line	I	View
17	39657661	T572I	S	S	Cell line		View
18	39657661	V1176F	S	S	Cell line	I	View
19	39657661	V213E	S	S	Cell line	I	View
20	39657661	V445P	S	S	Cell line	I	View
21	39657661	Y453F	S	S	Cell line	I	View
22	39657661	L452R	S	S	Cell line	G I	View
23	39657661	P681R	S	S	Cell line	G I	View
24	39657661	K417N	S	S	Cell line	G I	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.